Title
Category
Credits
Event date
Cost
  • Anticonvulsants
  • Antipsychotics
  • Bipolar Disorder
  • Mood Disorders
  • Suicide
  • Violence/Aggression
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Dr Suppes discusses guidelines for maintenance treatment of bipolar I disorder, with an algorithm for pharmacologic and psychosocial interventions.
  • Anticonvulsants
  • Antipsychotics
  • Bipolar Disorder
  • Mood Disorders
  • Suicide
  • Violence/Aggression
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
When should you rely on top-ranked treatment options for acute bipolar mania, and when should you skip down to lower-ranked options? Dr Suppes discusses.
  • Antipsychotics
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Finally, you can offer patients with tardive dyskinesia approved medications that reduce symptoms. In this CME, Dr Leslie Citrome reviews the evidence.
  • Antipsychotics
  • Bipolar Disorder
  • Depression
  • Diagnostic Tools
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Tardive dyskinesia must be detected early to minimize the risk of permanence. Dr Stephen Saklad provides a refresher in this brief CME activity.
  • Antipsychotics
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What should you rule out to diagnose tardive dyskinesia (TD)? How do treatment options differ? In this journal CME activity, Drs Citrome and Saklad team up to review the best clinical strategies.
  • Antipsychotics
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
In this CME, learn from an expert about how measurement-based care will help you improve depression outcomes in your patients.
  • Antipsychotics
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
How does tardive dyskinesia affect patients' work and relationships? Should TD be treated even if patients lack insight into its presence? Learn from this CME.
  • Antipsychotics
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
In brief videos, Drs McEvoy and Nierenberg discuss symptoms of tardive dyskinesia (TD), how to observe patients (whether in person or via telemedicine), and how to educate patients and families about TD.
  • Antipsychotics
  • Bipolar Disorder
  • Depression
  • Medical Conditions
  • Schizophrenia/ Schizoaffective Disorders
  • Weight
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
Certain antipsychotics are known to increase weight and the risk for diabetes. Could some medications for diabetes promote not only glycemic control but also weight loss in patients taking antipsychotics? In this CME activity, review the results of a small retrospective study.
  • Antipsychotics
  • Bipolar Disorder
  • Women’s Mental Health
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
What do data from a pregnancy registry demonstrate about the risk of major malformations among infants exposed to second-generation antipsychotics during the first trimester?

Pages